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Abstract
Numerous studies support the fact that a genetically diverse mouse population may be useful as an
animal model to understand and predict toxicity in humans. We hypothesized that cultures of
hepatocytes obtained from a large panel of inbred mouse strains can produce data indicative of
inter-individual differences in in vivo responses to hepato-toxicants. In order to test this hypothesis
and establish whether in vitro studies using cultured hepatocytes from genetically distinct mouse
strains are feasible, we aimed to determine whether viable cells may be isolated from different
mouse inbred strains, evaluate the reproducibility of cell yield, viability and functionality over
subsequent isolations, and assess the utility of the model for toxicity screening. Hepatocytes were
isolated from 15 strains of mice (A/J, B6C3F1, BALB/cJ, C3H/HeJ, C57BL/6J, CAST/EiJ, DBA/
2J, FVB/NJ, BALB/cByJ, AKR/J, MRL/MpJ, NOD/LtJ, NZW/LacJ, PWD/PhJ and WSB/EiJ,
males) and cultured for up to 7 days in traditional 2-dimesional culture. Cells from B6C3F1,
C57BL/6J, and NOD/LtJ strains were treated with acetaminophen, WY-14,643 or rifampin and
concentration-response effects on viability and function were established. Our data suggest that
high yield and viability can be achieved across a panel of strains. Cell function and expression of
key liver specific genes of hepatocytes isolated from different strains and cultured under
standardized conditions is comparable. Strain-specific responses to toxicant exposure have been
observed in cultured hepatocytes and these experiments open new opportunities for further
developments of in vitro models of hepatotoxicity in a genetically diverse population.
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The growing list of chemical substances in commerce and the complexity of the
environmental exposures from agents of natural origin represents an enormous challenge
with respect to the examination of the adverse health effect potential of exposures (Judson et
al., 2009). Current chemical hazard testing procedures can only address a small fraction of
agents as single exposures in order to provide sufficient information to meet the extensive
data needs under the current regulatory risk assessment guidelines (Judson et al., 2010).
Toxicity testing in the 21st century paradigm proposed a gradual transition from the apical
end-points to a strategy based on in vitro screening and molecular pathway analysis
(National Research Council, 2007). The data generated from the high-throughput assays will
provide a substantial proportion of the information needed for environmental decision-
making (National Research Council, 2007).
Primary hepatocytes constitute one of the most widely adopted in vitro models for
investigative hepatic toxicology and are used to evaluate hepatic toxicity, drug metabolism
or genotoxic potential of chemicals (Groneberg et al., 2002). In vitro culture systems offer
the potential to greatly reduce the number of animals needed to screen large numbers of
compounds for adverse effects (Gebhardt et al., 2003). In spite of the drawbacks of primary
hepatocyte cultures, including the absence of organ-specific heterotypic cell-cell interactions
and the gradual loss of expression of key liver-specific metabolism genes (Hewitt et al.,
2007), they provide useful alternatives to whole animal testing (Acosta et al., 1985;
Gebhardt et al., 2003).
Experimental studies that examine adverse effects of toxicants usually are unsuitable to
understand genetic factors that affect individual susceptibility to disease, do not take into
account the genetic diversity present within populations, and largely ignore gene-
environment interactions which affect risk (Harrill and Rusyn, 2008). Several recent studies
showed promise for a translational in vivo mouse-to-human research strategy which may aid
in identification of the genetic polymorphisms contributing to toxicity (Harrill and Rusyn,
2008). Panels of inbred mouse strains have been used to model a genetically diverse
population and discover susceptibility loci and genes (Harrill et al., 2009b), as well as to
understand genotype-independent toxicity responses (Harrill et al., 2009a). Liu et al. (Liu et
al., 2010), through an integrated genetic, transcriptional and metabolic analysis,
demonstrated that multiple genetic loci and an interacting network of metabolic factors
affect susceptibility to hepatotoxicity in a panel of 16 inbred mouse strains. Guo et al. (Guo
et al., 2006) used a panel of inbred mouse strains to reproduce the known inter-individual
variability in the metabolism of warfarin, specifically the generation of 7-hydroxywarfarin,
and determined that the phenotypic differences were associated with the polymorphisms in
the Cyp2c locus. Furthermore, a study which used liver microsomes isolated from the panel
of mouse strains demonstrated that genetic variation in Cyp2b9 and Ugt1a loci played a role
in the oxidative metabolism of α-hydroxytestosterone and glucuronidation of irinotecan,
respectively (Guo et al., 2007).
While these studies support the notion that a genetically diverse mouse population may be
useful as an animal model to understand and predict rare adverse drug events in humans,
they are based on the in vivo experiments. In this study, our goal was to establish whether in
vitro studies using primary cultured hepatocytes isolated from genetically distinct mouse
strains are feasible and can produce data that may be used for studies of in vivo adverse
effects of toxicants in a population-based model. We show that standardized isolation and
culture conditions can be established for hepatocytes from different mouse inbred strains,
and that a comparative in vitro/in vivo analysis of toxicant-induced responses is feasible.
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Primary hepatocytes were isolated from 4–6 week old male mice (strains A/J, B6C3F1,
BALB/cJ, C3H/HeJ, C57BL/6J, CAST/EiJ, DBA/2J, FVB/NJ, BALB/cByJ, AKR/J, MRL/
MpJ, NOD/LtJ, NZW/LacJ, PWD/PhJ and WSB/EiJ) from Jackson Laboratories (Bar
Harbor, ME). Mice were housed by strain in groups of three in a constant alternating 12-h
light and dark cycle and allowed free excess to food and water. All procedures were
approved by the Institutional Animal Care and Use Committee.
Isolation and culture of mouse hepatocytes
Primary mouse hepatocytes were isolated using a two-step collagenase perfusion method. In
brief, the animals were anesthetized with a cocktail of xylazine (2 mg/ml) and ketamine (20
mg/ml) and the liver was perfused in situ with warmed (37°C) saline solution without
magnesium and calcium (4 min) followed by a collagenase-containing buffer (8 min,
collagenase type IV, Sigma, St Louis, MO) through a catheter inserted through the atrium of
the heart into the superior vena cava. Livers were excised and disassociated in supplemented
William’s E culture medium (WEM) containing 10% FBS, 2 µg/ml gentamycin, 15 mM
HEPES, 0.1µM dexamethasome, 4 µg/ml insulin (Sigma) and 4 mM glutamax (Invitrogen).
Cells were filtered (100 micron nylon mesh) and the yield and viability were determined
using a trypan blue exclusion test (Sigma, 0.04%). Hepatocytes were further purified by
Percoll gradient centrifugation (Sigma). Viable hepatocytes were washed twice with the
same medium, transferred to a T-25 tissue culture flask, placed on an orbital shaker (50
rpms) and allowed to recover for 30 min at 37°C. Hepatocytes were suspended in WEM
containing 10% FBS and added to the 24-, or 96-well dishes (precoated with PureCol™
purified collagen or SL collagen type I, Sigma) at a density of 1.5×105 or 2×104 cells/well,
respectively. Cells were allowed to attach for 4 hr at 37°C and 5% CO2, medium was
changed to WEM without FBS and cells were cultured for another 24 hr before initiating
experiments. Medium was replaced on a daily basis.
Evaluation of cell viability and morphology
Phase contrast microscopy of the hepatocytes in the monolayer configuration was performed
at days 1, 3, 5 and 7 at a magnification of 200× with an Olympus inverted microscope
(Center Valley, PA). In some experiments, hepatocytes were stained with calcein AM and
ethidium homodimer-1 (Molecular Probes, Eugene, OR) to qualitatively assess the
proportion of live-to-dead cells and imaged using an Olympus microscope equipped with
epifluorescence illumination magnification of 200×). Cell culture medium was harvested on
a daily basis and centrifuged for 3 min at 14000 rpm; the supernatants were stored at −20°C
until assayed. Immediately following medium collection, cells were harvested in 200 µl of
TRIzol™ (Invitrogen, Carlsbad, CA) and stored at −80°C. Activity of lactate dehydrogenase
(LDH) and production of pyruvate and lactate from cultured cells was assessed by standard
enzymatic procedures (Bergmeyer, 1988). Urea synthesis was evaluated using BioAssay
Systems (Hayward, CA) QuantiChrom Urea Assay Kit as detailed by the manufacturer. All
reported values for pyruvate have been corrected to pyruvate content in the culture media.
Cytotoxicity of reference compounds was determined by measuring intracellular adenosine
triphosphate (ATP) content, glutathione levels, and caspase 3/7 activity using CellTiter-
Glo® Luminescent Cell Viability Assay, GSH-Glo™ Glutathione Assay, or Caspase-Glo®
3/7 Assay (Promega, Madison, WI), respectively, according to the manufacturer’s protocol.
Protein quantification was performed using BCA™ Protein Assay Kit (Pierce, Rockford, IL)
according to the manufacturer’s protocol.
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mRNA Isolation and Gene Expression Analysis by RT-PCR
TRIzol lysates homogenized using a 25 gauge needle and a 1 mL syringe and the RNA was
extracted from the samples using the Qiagen RNeasy Mini kit (Qiagen, Valencia, CA). RNA
concentrations were measured using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE) and quality was verified using the Agilent Bio-Analyzer
(Agilent Technologies, Santa Clara, CA). Total RNA (2 µg) was reverse transcribed using
random primers and the high capacity cDNA archive kit (Applied Biosystems, Foster City,
CA) according to the manufacturer’s protocol. The resulting cDNA was diluted to 1:100
with RNase-free H2O, mixed gently, aliquoted and stored at −20°C until required. The
following gene expression assays (Applied Biosystems) were used for quantitative real-time
PCR: acyl-coenzyme A oxidase 1 (Acox1, Mm00443579_m1); albumin (Alb,
Mm00802090_m1), carbamoyl-phosphate synthetase 1 (Cps1, Mm01256489_m1);
cytochrome P450, family 1, subfamily a, polypeptide 2 (Cyp1a2, Mm0048224_m1);
cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1, Mm00491127_m1);
cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp3a11, Mm00731567_m1);
cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10, Mm01188913_g1);
glutathione S-transferase, alpha 2 (Gsta2, Mm0083335_mH); hepatic nuclear factor 4, alpha
(Hnf4α, Mm00433964_m1); nuclear factor, erythroid derived 2, like 2 (Nrf2,
Mm00477784_m1); peroxisome proliferator activated receptor alpha (Pparα,
Mm00440939_m1); UDP glucuronosyltransferase 1 family, polypeptide A1 (Ugt1a1,
Mm02603337_m1); solute carrier organic anion transporter family, member 1b2 (Slco1b2,
Mm00451500_m1); and beta glucuronidase (Gusb, Mm00446753_m1). Reactions were
performed in a 96-well assay format. Each plate contained one experimental gene and a
housekeeping gene and all samples were plated in duplicate. Reactions were processed using
Roche 480 instrument (Roche Applied Science, Indianapolis, IN The cycle threshold (Ct) for
each sample was determined from the linear region of the amplification plot. The ΔCt value
for all genes relative to the control gene Gusb were determined. The ΔΔCt were calculated
using treated group means relative to strain-matched control group means. Fold change data
were calculated from the ΔΔCt values.
Data and Statistical Analysis
The software package GraphPad (version 4.0, Prism, La Jolla, CA) was used to plot the
time-course and gene expression data and the concentration-response curves, as well as to
calculate the EC50 values. Data are represented as mean values plus or minus the standard
deviation for the replicate wells for each condition with a minimum of 2 experimental
repeats, with each experimental repeat representing cells from a different hepatocyte
preparation. One-way ANOVA was used for statistical comparisons. In cases in which more
than one variable was compared (i.e., culture day and concentration) a two- way ANOVA
with Tukey’s multiple comparison test was utilized. A p value less than 0.05 was selected
prior to the study to determine statistical significance between groups.
Results
Assessment of viability and functionality of primary hepatocyte cultures from a panel of
strains
We chose 14 inbred mouse strains, representing fixed and reproducible unique genotypes
with a broad genetic diversity, comprising the priority group of strains that were
resequenced by NIEHS Center for Rodent Genetics (Frazer et al., 2007). In addition, we also
used B6C3F1 mice, an F1 cross between C57BL/6J and C3H/HeJ inbred lines, a strain
commonly used in toxicological research and by the National Toxicology Program (Allen et
al., 2004). Primary hepatocytes were isolated and cultured for up to 7 days to investigate
differences in their functionality due to their distinct genetic backgrounds (see Supplemental
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Figure 1A for the experimental design). Liver parenchymal cell yields (average of 59±13
million cells/mouse) and viability (93±4%) were comparable between strains regardless of
the lineage (Supplemental Table 1, Supplemental Figure 2). Strain-to-strain variability in
LDH release, pyruvate, lactate and urea production, markers of cell function, was observed
over 7-day culture period; however, the overall trends in time-dependent changes were
comparable (Supplemental Figure 3). Expression of several liver function-related genes was
evaluated in hepatocyte cultures (days 1 and 3) and whole liver samples from 7 randomly
selected strains (Supplemental Figure 4). Cells remained functional, as evidenced by
preserved levels of expression of Alb and Hnf4α, but became less metabolically active as
mRNA for Cyp4a10 and Ugt1a1 decreased markedly by 75–90% within the first 24 hours.
Independent isolations of primary hepatocytes produced consistent results when three
separate liver perfusions were performed from B6C3F1/J, C57BL/6J and NOD/LtJ strains
(Supplemental Table 1). Considerable consistency between biological replicates and strains
was observed in the biochemical endpoints of cell function (Figure 1). Baseline expression
of the genes involved in protein and urea metabolism (Alb, Hnf4α and Cps1) remained
comparable to that in the whole liver (Figure 2), while liver metabolism genes (Cyp1a2,
Cyp3a11, Cyp4a10, Gsta2, and Slco1b2) diminished dramatically with the exception of
Ugt1a1 which remained highly expressed. Strain-to-strain variability in expression was
observed that was consistent with the known role of genetic polymorphisms on liver gene
expression (Gatti et al., 2007).
In vitro toxicity testing in primary hepatocyte cultures
To investigate strain-specific sensitivity to chemical exposures we used several model
toxicants. Hepatocytes were isolated from B6C3F1/J, C57BL/6J and NOD/LtJ mice,
cultured and treated (for 24 hrs) with acetaminophen (0.3–30 mM), WY-14,643 (0.1–10
mM), or rifampin (1–100 µM) either 24 or 72 hrs post seeding (for experimental design, see
Supplemental Figure 1B). Three independent rounds of cell isolation, plating, and treatment
were performed. Cell viability was assessed by ATP production. Intracellular glutathione
content and expression of several marker transcripts were also evaluated.
Acetaminophen was selected as a metabolism-dependent hepatotoxicant. Primary
hepatocytes originating from 3 different strains exhibited a remarkably similar level of
cytotoxicity in 24 hr cultures (average EC50 ranged from 6.0 to 7.0 mM) (Figure 3A).
Interestingly, cells from C57BL/6J strain were somewhat more resistant to glutathione
depletion (EC50=6.0 mM as compared to 2.4–2.6 mM for other two strains). There were no
significant differences in intracellular glutathione content between strains in untreated
hepatocytes (Supplemental Figure 5). After 72 hrs in culture, primary cells from all strains
lost their sensitivity to acetaminophen in an equally similar manner (EC50≥30 mM for both
cell viability and glutathione depletion). Cyp2e1 and Nrf2 are key proteins involved in the
mechanism of acetaminophen-induced cytotoxicity in liver with the former necessary for
metabolic activation to the reactive thiol, N-acetyl-p-benzo-quinone imine, and the latter
playing a role in controlling expression of detoxification genes. While expression of Cyp2e1
was relatively high in 24 hr cultures (and treated with acetaminophen for additional 24 hrs)
in all strains, it was barely detectable in cells cultured for the longer duration (Figure 3B),
consistent with the observations of cytotoxicity. Expression of Nrf2 increased by about 2-
fold with time in culture; however, there were no differences observed between
concentrations or strains. No induction of either gene was observed with increasing
concentrations of acetaminophen.
WY-14,643 is a model peroxisome proliferator and inducer of Pparα, and it does not require
metabolic activation to exert liver-specific effects. Indeed, the length of time in culture had
little effect on cytotoxicity of WY-14,643 (Figure 4A). EC50s for both loss of ATP
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production and depletion of intracellular glutathione levels were quite consistent between
strains and culture duration. No consistent concentration-dependent induction of expression
of Pparα was observed (up to 1 mM); however, expression of Acox1 was affected
significantly (p<0.05 at 0.3 mM, concentration where to cytotoxicity was observed) by
treatment with WY-14,643 in hepatocytes from NOD/LtJ and B6C3F1/J mice (Figure 4B).
Rifampin is a species-specific hepatotoxicant and its liver toxicity is dependent on activation
of pregnane X receptor in human, but not mouse (LeCluyse, 2001b). As expected, little
cytotoxicity was observed for rifampin (up to 100 µM) in mouse hepatocytes of either strain
with both 24 and 72 hr cultures (Figure 5A). Mouse Cyp3a11 is known to be weakly
inducible in rodents by rifampin in vivo (LeCluyse, 2001b) and our data shows that in vitro,
induction may be strain-dependent as NOD/LtJ hepatocytes were able to maintain
expression of this gene and it was induced in 72 hr cultures (Figure 5B). Concentration of
rifampin was found to be a significant (p<0.05) variable for the expression of Cyp3a11 in
hepatocytes from NOD/LtJ strain.
Discussion
Cell-based approaches are well suited for hazard identification, prioritization of
environmental chemicals, and drug safety screening (Greer et al., 2010). Furthermore, in
vitro toxicity experiments can generate large amounts of information on biological
mechanisms of action, including compound’s potential for metabolism-mediated toxicity
and inter-individual variability (Mingoia et al., 2007). While inter-individual variability
following xenobiotic exposures in primary human hepatocyte cultures is a well-established
phenomenon (Goyak et al., 2008), it is frequently viewed as an impediment to in vitro
experiments with primary hepatocytes. Our study not only demonstrates the feasibility and
utility of a cultured hepatocyte model developed from a mouse diversity panel, but also
shows the consistency of viability and function of the cells isolated from the individual
animals of the same strain across the panel. Thus, the mouse hepatocytes derived from
multiple strains may serve as an infinitely reproducible in vitro model of a genetically
diverse population.
While standardized isolation and cell culture conditions are crucial to ensure “phenotypic
consistency” of the cultures derived from a panel of genetically distinct mouse strains, there
are important limitations to the conventional cultures with regards to maintenance of liver-
like function in longer-term cultures (Swift and Brouwer, 2010). In addition, mouse
hepatocytes are more difficult to maintain in a functional state than rat or human cells
(Swales et al., 1996), likely due to a much higher metabolism rate and oxygen demand.
Clearly, much work remains to be done to determine appropriate conditions that would
allow maintenance of mouse hepatocytes in culture in a differentiated state past culture day
3.
There are many factors that regulate maintenance of the liver-like phenotype in vitro
including cell-cell communications, cell shape, organization and distribution of the
cytoskeleton and extracellular matrix interactions (Musat et al., 1993; Stamatoglou and
Hughes, 1994; Berthiaume et al., 1996; Oda et al., 2008). Cell-cell contacts help maintain
liver-specific function and normal gene expression through adhesion dependent signal
transduction pathways mediated by the Rho-family of small GTPases (Etienne-Manneville
and Hall, 2002). Indeed, advanced culture systems have been developed to allow for better
retention of hepatocyte cytoarchitecture and retention of the in vivo gene expression profiles
of liver. These include co-culture with other liver-derived or non-liver cell types, exposing
hepatocytes to a gel substratum, culture in collagen gel sandwiches, and culture in spheroids
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and in 3D bioreactors (LeCluyse, 2001a; Sivaraman et al., 2005; Khetani and Bhatia, 2008;
Godoy et al., 2009).
Liver-specific transcription factors, including HNF4α, are involved in the regulation of a
number of hepatic genes (Akiyama and Gonzalez, 2003). Cultured hepatocytes in our study
were able to maintain the expression of HNF4α out to culture day 3 at levels comparable to
whole liver; however, the cells failed to maintain expression of many genes relating to phase
I and II metabolism past culture day 3. HNF4α is one of many factors in a complex
regulatory network that mediates the expression of many hepatic genes (Chen et al., 1994;
Akiyama and Gonzalez, 2003). Monolayer confluency also influences the expression and the
inductive capability of several cytochrome P450 enzymes whose expression has been shown
to decrease with the loss of confluence (Hewitt et al., 2007), and our observation of loss of
confluency due to spindle-like cell transformation may be the key reason for loss of
metabolism function.
Despite the challenges in maintaining liver-like phenotype in cell culture, the hepatocytes
derived from mice of the same strain exhibited consistent and reproducible features in
independent isolations. Furthermore, independent isolations exhibited low variation in
cytotoxicity experiments with three model chemicals, acetaminophen, WY-14,643 and
rifampin. This outcome points to the potential utility of the in vitro hepatocyte cultures as
reproducible proxies for population diversity. Not only can cells be derived repeatedly from
the same strain and expected to have a consistent in vitro phenotype, thus eliminating the
concerns over the unpredictable nature of batches of human cells which are not renewable,
but it is also possible to study the potential haplotype associations since the mouse cells have
known genotypes, while the human cells do not.
Mouse strain-specific responses to acute acetaminophen toxicity have been demonstrated in
in vivo studies (Harrill et al., 2009b; Liu et al., 2010). When liver injury was evaluated 24
hrs after a single large dose (300 mg/kg, i.g.) of acetaminophen, NOD/LtJ mice exhibited
mild liver necrosis and inflammation (~10%), while B6C3F1 mice had more than 80% of
the parenchyma affected, and C57BL/6J strain exhibited an intermediate phenotype (20–
25%) (Harrill et al., 2009b). Polymorphisms in inflammatory-mediator response genes were
shown to be associated with liver injury in the population of mice, suggesting that the degree
of inflammation, defined by the resident macrophages and infiltrating neutrophils, are key
factors in the clinical outcome of acetaminophen toxicity. At the same time, this study also
reported that elevations of serum alanine aminotransferase activity were comparable
between these strains 4 hrs after dosing. Thus, the fact that we observed no discernable
strain differences in hepatocyte viability following the drug challenge in vitro further
supports the crucial importance of nonparenchymal cells in the liver damage in vivo
(DeLeve et al., 1997; Adams et al., 2010).
Hepatic inflammation is commonly found in a variety of liver diseases and during drug-
induced liver toxicity and resident hepatic macrophages, Kupffer cells, have been shown to
be key players in determining the outcomes of toxicity through their immune-modulating
role (Cover et al., 2006). In addition, Kupffer cells can also be involved in mitogenic
responses by affecting proliferation of hepatocytes (Rose et al., 1999), or regulating hepatic
transport protein expression during drug-induced liver injury (Campion et al., 2008). Other
non-parenchymal cells can also play a significant role in mediating hepatic responses to
xenobiotics. For example, hepatic stellate cells, when activated, are the major mediators of
matrix formation in response to liver injury (Friedman, 2008) and also play a direct role in
the inflammatory process as they secrete chemokines and express cell adhesion molecules
which can mediate lymphocyte adhesion (Holt et al., 2009). However, capturing complex
heterotypic liver cell interactions in vitro is a challenge. The canonical hepatocyte-enriched
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primary cell isolations obtained by collagenase perfusion and low-speed centrifugation
results in a cell population that contains 5–10% non-parenchymal cells within the majority
(90–95%) being liver parenchymal cells even though the latter comprise ~60% of liver cells
by number in vivo (Michalopoulos et al., 1999; Peters et al., 2000).
Hepatic intracellular glutathione is also a well known modifier of acetaminophen
hepatotoxicity (Mitchell et al., 1973). Evaluation of glutathione content in the cultured
hepatocytes from the three strains revealed notable differences in the rate of glutathione
depletion in response to increasing concentrations of acetaminophen. However, while
B6C3F1 hepatocytes showed a steep concentration-dependent loss of reduced glutathione,
commensurate with high sensitivity to liver injury in vivo, NOD/LtJ hepatocytes’ response
was quite similar, suggesting that hepatocyte monocultures may not be indicative of the
degree of overt toxicity which depends on non-parenchymal cells. Additional studies need to
be conducted in more complex culture systems to further investigate the relationship
between the genotype and sensitivity to acetaminophen.
Furthermore, our results indicate a significant reduction in the cytotoxicity of
acetaminophen when tested against primary hepatocytes cultured out to day 3, which
suggest a significant change in the metabolic capacity of the cultured hepatocytes.
Acetaminophen toxicity is a metabolism dependent pathway via bioactivation by Cyp2e1
which is involved in the formation of the reactive thiol (Kaplowitz, 2005). Indeed, the
observed decrease in sensitivity to acetaminophen correlates with the progressive loss of
Cyp2e1 expression. These findings are consistent with previous reports which found
metabolic capacity, transport functions and other enzyme activities to diminish dramatically
in culture (Richert et al., 2002; Luttringer et al., 2002). This relationship between toxicity to
hepatocytes in vitro and drug-induced liver injury in vivo remains poorly defined and
highlights an important limitation of over-reliance on the in vitro testing alone without
appropriate studies in vivo, or in more complex cell culture systems (Greer et al., 2010).
A model peroxisome proliferator WY-14,643 was used as an agent that requires no
metabolic biotransformation to exert either in vivo or in vitro effects. Indeed, the number of
days in culture, a significant variable in response to treatment with acetaminophen, appeared
to have little effect on cytotoxicity of WY-14.643. Even though cytotoxicity was observed,
similar to the high dose effects in vivo (Woods et al., 2007), the phenotype of concern is
induction of cell proliferation and hepatomegaly due to peroxisome proliferation. While
Acox1 expression was maintained in mouse hepatocytes, it was not inducible by treatment,
contrary to the observation in rat hepatocytes (Berthou et al., 1995). Increase in DNA
synthesis caused by peroxisome proliferators in vivo is dependent on the activation of
Kupffer cells (Rose et al., 2000), and co-cultured systems may be necessary to reproduce
this phenotype. Parzefall et al demonstrated that peroxisome proliferators do not influence
DNA synthesis in isolated rat hepatocytes, but addition of cytokines can replicate the in vivo
effect in primary cultures (Parzefall et al., 2001).
Treatment with increasing concentrations of rifampin had little effect on ATP and
glutathione in cells from all strains. Even at the highest concentration (100 µM) tested, only
about a 20–25% effect was observed irrespective of the time in culture. There are significant
species differences in response to pregnane X receptor ligands between humans and rodents
(Jones et al., 2000). Rifampin and other drugs are known to activate the human receptor, but
are weak activators of the rodent receptor. Interestingly, expression of Cyp3a11 was weakly
inducible in response to treatment with rifampin. Other investigators (Tsutsui et al., 2006)
have shown that in 129/sv mice-derived hepatocytes Cyp3a11 expression is diminished over
2.5 days in culture, a trend which was similar to one observed here; however, the
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inducibility of this gene by a weak ligand shows that the pregnane x receptor is functional,
similar to the observations of Shenoy et al (Shenoy et al., 2004).
In summary, our current work supports the utility of an in vitro toxicogenetic model for
studying mechanisms of drug-induced hepatotoxicity. While our data supports the concept
that cultures of hepatocytes derived from a mouse diversity panel can potentially be utilized
as a tool to conduct population-based toxicity studies in vitro, it also highlights the need for
further improvements through co-culture (Khetani and Bhatia, 2008) or 3-dimesional flow
(Griffith and Swartz, 2006) techniques. On one hand, it is essential to establish an in vitro
model which may allow research on the biological mechanisms mediated by underlying
genetic determinants and elucidation of the factors contributing to inter-individual responses
to toxicity. Indeed, population-based in vitro models, albeit not liver-specific, are being used
to provide insights into the genetic factors contributing to inter-individual susceptibility in
humans by identifying the unique genotype-specific drug-induced toxicity and gene
expression (Welsh et al., 2009). On the other hand, our results suggest that development of a
multi-cell liver-derived in vitro model which preserves baseline hepatic function is
necessary. While this manuscript demonstrates the importance of optimizing cell isolation
and culture conditions for hepatocytes, additional studies which incorporate non-
parenchymal cells are needed to construct population-based in vitro models that may
accurately predict in vivo responses to a wide range of hepato-toxicants.
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Refer to Web version on PubMed Central for supplementary material.
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Functional characterization of cultured hepatocytes isolated from 3 mouse strains.
Hepatocytes were isolated from B6C3F1/J, C57BL/6J and NOD/LtJ (males, n=3) and
cultured in 24-well plates in a conventional monolayer up to day 7. Media was harvested
daily and activity of lactate dehydrogenase, serum concentrations of urea, pyruvate and
lactate, and intracellular concentrations (amount in all cells in each well on days 1, 3 and 7)
of ATP and glutathione were quantified. Data shown as mean±SD of independent biological
replicates.
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Analysis of reproducibility of gene expression in cultured hepatocytes isolated from 3
mouse strains. mRNA levels of Alb, Cps1, Hnf4α, Cyp1a2, Cyp3a11, Cyp4a10, Ugt1a1,
Gsta1, and Slco1b2 was assessed using quantitative RT-PCR in liver tissue (black bar) and
hepatocytes cultured for 1 (white bar) or 3 (grey bar) days. Data (mean±SD of biological
replicates) was normalized to expression levels in whole liver samples.
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Effects of acetaminophen on hepatocytes derived from 3 mouse strains. Hepatocytes were
isolated from B6C3F1/J, C57BL/6J and NOD/LtJ (males, n=3) and cultured in 96-well
plates in a conventional monolayer for 24 or 72 hr and exposed to acetaminophen (0.3, 1, 3,
10 and 30 mM) or vehicle (dimethyl sulfoxide, 0.5%) for additional 24 hr. Hepatocytes were
harvested on day 2 (filled circles or white bars), or 4 (filled squares or black bars) of culture.
(A) Assessment of cytotoxicity using intracellular ATP and glutathione (GSH) levels. Data
(mean±SD of biological replicates) was normalized to the values in vehicle-treated cells. (B)
mRNA levels of Cyp2e1 and Nrf2 were assessed using quantitative RT-PCR. Data (mean
±SD of biological replicates) was normalized to expression level of Gusb.
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Effects of WY-14,643 (0.1, 0.3, 1, 3 and 10 mM) on hepatocytes derived from 3 mouse
strains. Cells were isolated, cultured, and data collected as detailed in the legend to Figure 3.
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Effects of rifampin (1, 3, 10, 30 and 100 µM) on hepatocytes derived from 3 mouse strains.
Cells were isolated, cultured, and data collected as detailed in the legend to Figure 3.
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